Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
DaVita HealthCare Partner
(NY:
DVA
)
141.12
-1.51 (-1.06%)
Official Closing Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DaVita HealthCare Partner
< Previous
1
2
3
4
5
6
7
8
Next >
If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today
December 07, 2022
Via
Benzinga
Warren Buffett Now Owns 20% or More of These 5 Companies
November 22, 2022
Which are these big Buffett bets are the best picks for investors?
Via
The Motley Fool
$1000 Invested In This Stock 20 Years Ago Would Be Worth $8,500 Today
November 21, 2022
Via
Benzinga
$1000 Invested In DaVita 20 Years Ago Would Be Worth This Much Today
November 04, 2022
DaVita (NYSE:DVA) has outperformed the market over the past 20 years by 3.82% on an annualized basis producing an average annual return of 11.29%. Currently, DaVita has a market capitalization of $6.29...
Via
Benzinga
DaVita Earnings Perspective: Return On Capital Employed
November 03, 2022
Pulled from Benzinga Pro data, DaVita (NYSE:DVA) showed a loss in earnings since Q2, totaling $164.69 million. Sales, on the other hand, increased by 0.75% to $2.95 billion during Q3.
Via
Benzinga
Around $134 Million Bet On This Stock Up 46% Year-To-Date? 3 Stocks Insiders Are Buying
November 02, 2022
Although US stocks closed lower on Tuesday, there were a few notable insider trades.
Via
Benzinga
Analyst Ratings for DaVita
October 31, 2022
Over the past 3 months, 5 analysts have published their opinion on DaVita (NYSE:DVA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's...
Via
Benzinga
DaVita (DVA) Q3 2022 Earnings Call Transcript
October 28, 2022
DVA earnings call for the period ending September 30, 2022.
Via
The Motley Fool
Stocks That Hit 52-Week Lows On Monday
October 31, 2022
During Monday's session, 96 stocks hit new 52-week lows.
Via
Benzinga
Chevron To Rally Around 21%? Here Are 5 Other Price Target Changes For Monday
October 31, 2022
Raymond James raised Chevron Corporation (NYSE: CVX) price target from $188 to $215. Raymond James analyst Justin Jenkins maintained the stock with an Outperform rating. Chevron shares fell 1.1% to...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Upgrades
Via
Benzinga
Weibo, XPeng, Li Auto And Other Big Losers From Friday
October 31, 2022
U.S. stocks closed higher on Friday, with the Dow Jones gaining more than 800 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
October 31, 2022
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.
Via
Benzinga
Nasdaq Climbs 275 Points; S&P 500 Rises Over 2%
October 28, 2022
U.S. stocks extended gains toward the end of trading, with the Nasdaq Composite surging more than 200 points on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 28, 2022
Gainers
Via
Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $900 Today
October 28, 2022
DaVita (NYSE:DVA) has outperformed the market over the past 20 years by 4.09% on an annualized basis producing an average annual return of 11.52%. Currently, DaVita has a market capitalization of $6.63...
Via
Benzinga
Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
October 28, 2022
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) surged 179% to $3.6301.
Via
Benzinga
Dow Jumps 600 Points; Crude Oil Down Over 1%
October 28, 2022
U.S. stocks extended gains midway through trading, with the Dow Jones surging more than 600 points on Friday.
Via
Benzinga
2 Market-Moving Stocks You Can't Afford to Ignore
October 28, 2022
Friday's market action saw volatility both upward and downward.
Via
The Motley Fool
US Stocks Mostly Higher; Dow Surges 300 Points
October 28, 2022
U.S. stocks traded mostly higher this morning, with the Dow Jones surging more than 300 points on Friday.
Via
Benzinga
Dialysis Provider DaVita Slashes FY22 Earnings Outlook Citing Continued Pandemic Impact, Shares Fall
October 28, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 28, 2022
Gainers Nuvalent (NASDAQ:NUVL) stock increased by 15.9% to $25.5 during Friday's pre-market session. The company's market cap stands at $1.2 billion.
Via
Benzinga
Recap: DaVita Q3 Earnings
October 28, 2022
DaVita (NYSE:DVA) reported its Q3 earnings results on Friday, October 28, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings DaVita missed estimated earnings by...
Via
Benzinga
Earnings Scheduled For October 28, 2022
October 28, 2022
Companies Reporting Before The Bell • TAL Education (NYSE:TAL) is projected to report quarterly earnings at $0.01 per share on revenue of $242.62 million.
Via
Benzinga
DaVita's Earnings: A Preview
October 27, 2022
DaVita (NYSE:DVA) is set to give its latest quarterly earnings report on Friday, 2022-10-28. Here's what investors need to know before the announcement. Analysts estimate that DaVita will report an...
Via
Benzinga
7 Warren Buffett Stocks to Buy and Hold for the Next Decade
October 17, 2022
Intelligent investors know that purchasing Warren Buffett stocks to buy and hold will work in the long-term.
Via
InvestorPlace
Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells
October 12, 2022
You may remember learning that mitochondria are the powerhouse of the cells, but do you know the dangers that result if these cell superheroes get sick?
Via
TheNewswire.com
Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells
October 11, 2022
You may remember learning that mitochondria are the powerhouse of the cells, but do you know the dangers that result if these cell superheroes get sick?
Via
Benzinga
The 7 Most Undervalued Mid-Cap Stocks to Buy Now
September 26, 2022
Here are some of the most undervalued mid-cap stocks to buy now.
Via
InvestorPlace
Federman & Sherwood Investigates DaVita, Inc. for Data Breach
September 12, 2022
From
Federman & Sherwood
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.